Dr Agarwal’s Q1 revenue rises 26% as broker targets climb
Dr Agarwal’s Health Care reported Q1 FY27 revenue of ₹614 crore and PAT of ₹55 crore, up 26% and 44.6% year on year. Same-store sales grew 16% as the eye-care chain continued centre expansion; Morgan Stanley and Jefferies raised their target prices.
Dr Agarwal’s Health Care posted strong Q1 FY27 growth, with revenue up 26% and PAT up 44.6%, alongside its largest-ever quarterly eye-care-centre expansion. Morgan Stanley and Jefferies raised targets, citing premiumisation, same-store sales and expansion prospects.
Why this matters
No related recent signals were provided. The Q1 FY27 update shows Dr Agarwal’s combining 16% same-store sales growth with centre expansion, while Morgan Stanley and Jefferies lifted target prices.
Retail-company signals are accelerating, up 206857% QoQ.